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W e d e s c r ib e  th e  p r o p e r t ie s  o f  a  fa m ily  o f  2 2 -a m in o  a c id  p e p tid e s , th e  ju -cono tox ins, w h ic h  a r e  
w  u se fu l p ro b e s  f o r  in v e s t ig a t in g  v o lta g e -d e p e n d e n t so d iu m  c h a n n e ls  o f  e x c ita b le  t is su e s . T h e  #t-
c o n o to x in s  a r e  p r e s e n t  in  th e  v e n o m  o f  th e  p isc iv o ro u s  m a r in e  sn a il ,  C o n u s  g e o g r a p h u s  L . W e 
h a v e  p u r i f ie d  se v e n  h o m o lo g s o f  th e  M -conotoxin s e t a n d  d e te rm in e d  th e i r  a m in o  a c id  se q u en c es , 
a s  fo llo w s, w h e r e  H y p  =  f r a n s -4 -h y d ro x y p ro l in e .
GIIIA R-D -C-C-T-Hyp-Hyp-K-K -C-K-D*R-Q*C*K-Hyp-Q-R-C-C-A-NH 2
[Pro6]GIIIA R*D"C'C*T'P*Hyp'K-K -C-K*D*R*Q‘C ‘K -H yp-Q 'R 'C *C 'A -N H 2
[Pro7]GIIIA R *D *C 'C -T 'H yp 'P 'K 'K 'C 'K 'D *R 'Q *C 'R *H yp*Q *R *C 'C -A-NH 2
GIIIB R -D -C -C -T -H ypH yp-R -K -C -K -D -R -R -C -K -H yp-M -K -C -C -A N H 2
[Pro6]GIIIB R-D -C -C -T-P-H yp-R *K *C -K -D -R -R -C -K -H yp-M -K -C -O A -N H 2




GIIIC R-D -C -C -T*H yp-H yp-K -K -C -K *D -R R -C -K -H yp-L-K -C -C -A -N H 2
m . U s in g  th e  m a jo r  p e p t id e  (G IIIA ) in  e le c tro p h y s io lo g ic a l s tu d ie s  o n  n e rv e -m u s c le  p r e p a ra t io n s
a n d  in  s in g le  c h a n n e l s tu d ie s  u s in g  p la n a r  lip id  b i la y e r s ,  w e  h a v e  e s ta b l is h e d  th a t  th e  to x in  
b lo c k s  m u sc le  so d iu m  c h a n n e ls ,  w h ile  h a v in g  n o  d is c e rn ib le  e f fe c t o n  n e r v e  o r  b r a in  so d iu m  
c h a n n e ls .  In  b i la y e r s  th e  b lo c k in g  k in e t ic s  o f  G IIIA  w e r e  d e r iv e d  b y  s ta t is t ic a l  a n a ly s is  o f  
d is c re te  t r a n s i t io n s  b e tw e e n  b lo c k e d  a n d  u n b lo c k e d  s ta te s  o f  b a t ra c h o to x in -a c t iv a te d  so d iu m  
c h a n n e ls  f ro m  r a t  m u sc le . T h e  k in e t ic s  c o n fo rm  to  a  s in g le - s ite ,  r e v e r s ib le  b in d in g  e q u i l ib r iu m  
w ith  a  v o lta g e -d e p e n d e n t b in d in g  c o n s ta n t .  T h e  m e a s u re d  v a lu e  o f  th e  e q u i l ib r iu m  K D f o r  G IIIA  
is  1 0 0  nM a t  O m V , d e c re a s in g  e -fo ld /3 4  m V  o f  h y p e rp o la r iz a tio n .  T h is  v o lta g e  d e p e n d e n c e  o f  
b lo c k in g  is  s im ila r  to  t h a t  o f  te tro d o to x in  a n d  s a x ito x in  a s  m e a s u re d  b y  th e  sa m e  te c h n iq u e . T h e  
t is su e  s p e c if ic ity  a n d  k in e t ic  c h a r a c te r is t ic s  su g g e s t th a t  th e  p -c o n o to x in s  m a y  s e rv e  a s  u se fu l 
l ig a n d s  to  d is t in g u is h  so d iu m  c h a n n e l s u b ty p e s  in  d i f f e r e n t  tis su e s .
V
While characterization of the voltage-activated sodium Electrophorus (5-7), from chick cardiac muscle (8), rat skele-
channel as mediator of the inward sodium current of the tal muscle (9), and rat brain (10).
action potential was established by electrophysiological meth- At the present time, although all preparations contain a
ods (1), recent progress has been made in the biochemical major large subunit of molecular weight between 230,000-
characterization of sodium channel proteins (2, 3). The basic 300,000, there are significant differences reported among the
strategy has been to use labeled toxins that bind tightly to various isolated sodium channel proteins (7-10). It is not clear
the channel proteins to assist in their detection, assay, and whether these differences stem from differences in laboratory
purification. The major toxins used for this purpose are gua- techniqueSi assays used, evolutionary divergence of the chan-
nidinium toxins such as tetrodotoxin and saxitoxin, alkaloids nel> Qr different tissue types
of the vertatridine group, and a set of small proteins from We gh()w ^  ^  ified neurotoxins b r i b e d  in this
scorpion venoms (for reviews, see Refs. 2-4). Using these , ,, , . u  , • -t n ~ ~, . i i report, the u-conotoxins* from the m arine snail Lonus geogra-toxins as specific ligands, purified sodium channel prepara- . : . , , , , ,
tions have been described from the electric organ of the eel Phus’ ^crim inate strongly between nerve and muscle sodium
---------------------------------------------------------------------------------------  1 We are attempting to be systematic in our naming of the peptides.
* This work was supported by Research Grants GM22737, “Conotoxin” is used to include all such molecules isolated from Conus
NS15543, and NS00465 from the National Institutes of Health, and snails. Capital Roman letters indicate species thus: G, C. geographus;
by the Muscular Dystrophy Association. The costs of publication of M, C. magus', T. C. textile; S. C. striatus; etc. Roman numerals
this article were defrayed in part by the payment of page charges. distinguish various individual toxins, with closely related forms hav-
This article must therefore be hereby marked “advertisement” in ing Roman letters appended, as conotoxin GIIIA. When a physiolog-
accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ical mode of action is known, we use a Greek letter to refer to the
§ Postdoctoral Fellow of the Muscular Dystrophy Association. class as follows: a, acetylcholine receptor toxins; n, muscle sodium






















channels, lending support for the idea that there may be 
significant differences between the proteins. Existence of the 
muscle-selective ^-conotoxins could first be inferred from 
work on crude venom by Endean and co-workers (11, 12). In 
their physiological characterization of C. geographus venom, 
these investigators noted that the venom did not affect nerve 
action potentials, but abolished muscle action potentials even 
when the muscle was directly stimulated. Spence et al. (13) 
described the isolation of a toxin (Toxin III) which, by amino 
acid composition, is clearly a member of the ^-conotoxin 
family as defined in this report. They showed that Toxin III 
preferentially abolished muscle action potentials; however, 
they reported that the purified preparation would slowly and 
irreversibly abolish nerve action potentials and noted the 
discrepancy with Endean’s results with the crude venom. 
Further biochemical characterization of this toxin was carried 
out in our laboratories, where the purified toxin was shown 
to contain hydroxyproline (14), and by a group in Japan who 
purified and determined the amino acid sequences of two 
toxins of this group (15, 16).
In this report, we provide a more comprehensive character­
ization of the /x-conotoxin family than has been available to 
date. Seven homologous /i-conotoxin peptides are described; 
four of the variants appear to be post-translational processing 
intermediates. We also provide definitive biochemical and 
electrophysiological evidence that one toxin in this series (jj.- 
conotoxin GIIIA) does indeed directly block muscle Na chan­
nels. Single channel experiments on batrachotoxin-activated 
sodium channels incorporated into planar bilayers, from a rat 
muscle membrane preparation, provide the first detailed study 
of the kinetics of /i-conotoxin action. The kinetics of blocking 
are similar to those of the classic guanidinium toxins, tetro- 
dotoxin and saxitoxin, as studied by the same method. In 
contrast to these latter toxins, however, ^-conotoxin exhibits 




C. geographus venom was extracted (17), and soluble proteins and 
peptides were fractionated on a column of Sephadex G-25 (18) as 
previously described. Four broad peaks were eluted from the G-25 
column, the first appearing at the void volume. The jn-conotoxins 
were found in the second peak. This material was fractionated by 
reversed-phase HPLC2 using a Supelco semiprep column (1.25 x 25 
cm; 5-^m particle size; C18, not end-capped; 25 °C) at a flow rate of
3 ml/min. A gradient was applied using Solvent A, 0.1% aqueous 
trifluoroacetic acid, and Solvent B, 0.1% trifluoroacetic acid in 60% 
(v/v) acetonitrile (19). A linear gradient from 15-80% Solvent B was 
developed in 35 min. Under these conditions the /i-conotoxins, iden­
tified by intraperitoneal assay in mice, are the first three major peaks 
eluted between 15 and 30% Solvent B, with ^-conotoxin GIIIA being 
present in much greater amounts than the others. Each active peak 
was further purified by rechromatography on a VYDAC C18 column 
(0.46 X 25 cm; 5-jim particle size; not end-capped).
Amino Acid Analysis
Samples of peptides were hydrolyzed in vacuo with 6  n HC1, at 
105 °C for 24 h. Acid was removed by drying in a Speed-Vac (Savant 
Instruments), and the residue was analyzed by ion-exchange chro­
matography on a Beckman Model 121 amino acid analyzer.
2 The abbreviations used are: HPLC, high-performance liquid 
chromatography; Hyp, trares-4-hydroxyproline; PTH, phenylthio- 
hydantoin; Cys(Cm), carboxymethylcysteine; dns, 5-dimethylamino- 
naphthalene-l-sulfonyl; MOPS, 4-morpholinepropanesulfonic acid.
Reduction and Carboxymethylation
Since only small amounts of conotoxins GIIIB and GIIIC were 
available, we carried out reduction and alkylation under conditions 
that allowed us to put the complete reaction mixture into the sequen­
cer cup. Approximately 5-10 nmol of peptide was dissolved in 25 m1 
of N-ethylmorpholine/water (1:1 by volume). Fifteen microliters of a 
2 % solution of tributylphosphine in n-propyl alcohol (2 0 ) were then 
added, and the mixture was incubated under N2 for 15 min at 57 °C. 
Twenty microliters of a 0.2 M solution of iodoacetic acid were then 
added. After a further 15 min (N2, dark) excess iodoacetate was 
reacted by addition of 1 of mercaptoethanol. These conditions had 
been found to be satisfactory in trial experiments with vasopressin.
Sequence Analysis
Manual Methods—A sample of 182 nmol of conotoxin GIIIA was 
reduced with dithiothreitol and alkylated with iodoacetamide. The 
carboxyamidomethylated toxin was repurified by reversed-phase 
HPLC on the VYDAC column using conditions similar to those 
described above. It was then digested for 3 h at 37 °C with clostripain 
(50 /id of a 1 mg/ml solution in 0.025 M potassium phosphate, pH 7.5, 
containing 0.2 mM calcium acetate and 2.5 mM dithiothreitol) (21). 
The digest was fractionated on the VYDAC column using a linear 
gradient of acetonitrile in 0 .1 % trifluoroacetic acid, the eluate being 
monitored at 214 nm. Peaks were collected manually, and the peptides 
were subjected to amino acid analysis and to degradation by phen- 
ylisothiocyanate using Tarr’s procedure (2 2 ). Phenylthiohydantoin 
derivatives were analyzed by reversed-phase HPLC, using the method 
of Hunkapiller and Hood (23).
Automated Sequencing—Samples of all M-conotoxins were reduced, 
carboxymethylated, and analyzed in a Beckman 890D spinning cup 
sequencer (24). We used a 0.1 M Quadrol program, as supplied by the 
manufacturer, and a combined wash with benzene and ethyl acetate. 
Two milligrams of polybrene (25) were used as a carrier; before 
applying the toxin samples, 100 nmol of Ser-Ala was added to the 
Polybrene and subjected to five cycles of degradation. Conversion of 
the fractions was carried out using 2 0 0  n\ of 1  n HC1 containing 0 .1 % 
dithiothreitol (w/v). After removal of the acid in a Speed-Vac, samples 
were dissolved directly in 50 1^ of 0.1% trifluoroacetic acid, containing 
20% (v/v) acetonitrile. This diluent, used for sample application on 
HPLC, greatly improves the stability of PTH-Cys(Cm). The PTH 
derivatives were analyzed as described above.
Carboxyl Region ofG-IIIC—A clean sequence of GIIIC was obtained 
to residue 19, and the results beyond that point were compatible with 
the “expected” sequence Cys-Cys-Ala (see below). To improve our 
chance of obtaining definitive evidence on this from our remaining 
material, we first performic acid-oxidized the peptide (26). After 
thoroughly drying the peptide we then dissolved it in 50 1^ of 50% 
(v/v) iV-ethylmorpholine and reacted it with 10 /x 1 of acetic anhydride. 
The sample was dried in vacuo with several additions of water, until 
only a thin oily film remained. It was then digested for 2 h at 37 °C 
with 5 ng of trypsin in 50 iA of 0.2 M JV-ethylmorpholine acetate, pH
8.5. The digest was diluted with 200 /A of water and applied directly 
to the sequencer cup, which contained precycled Polybrene. For this 
sample we used a 0.25 M Quadrol program with separate benzene and 
ethyl acetate washes.
Physiological Methods
Cutaneous pectoralis nerve-muscle preparations were dissected 
from Rana pipiens. Each preparation was pinned out in a rectangular 
trough constructed of Sylgard. Conventional intracellular recording 
techniques were used. The motor nerve to the muscle spanned a 
vaseline gap and was stimulated with platinum wires placed on either 
side of the gap. A thin vaseline-coated bar, constructed of Sylgard, 
was placed transversely over the muscle near its myocutaneous end; 
this partitioned the trough into two compartments spanned by the 
muscle. Direct stimulation of the muscle was performed by passing 
current through platinum electrodes placed in each compartment. 
Excitation-contraction coupling was blocked by formamide treatment 
(27). The experiments were conducted at room temperature.
Single-channel Studies in Lipid Bilayers
Single sodium channels were inserted from native plasma mem­
brane vesicles from rat brain and rat muscle into planar phospholipid 
bilayers using the methods of Moczydlowski et al. (28) and Krueger 
et al. (29). Statistical analysis of GIIIA blocking kinetics was carried 





















Purification of /i-Conotoxins—In a typical preparation 43 
mg of protein, extracted from 724 mg of crude venom, was 
applied to the Sephadex G-25: recovery of protein was 39 mg 
(90%). Peptides with ji-conotoxin activity eluted earlier than 
did the previously described a-conotoxins (GI, GII, and GIA; 
Ref. 30) and co-conotoxins (31). The pool containing the n- 
conotoxins (4.4 mg, total protein) was chromatographed on 
reversed-phase HPLC; the toxins eluted betwen 9 and 18% 
acetonitrile, indicating a very hydrophilic nature for peptides 
of this size. Conotoxins GIIIA (35%), GIIB (9%), and GIIIC 
(4%) accounted for approximately half of the material re­
covered from the column. In a later preparation, several minor 
peaks of activity were obtained as satellites of the major 
peaks. These are shown in Fig. 1, with positions of the major 
toxins indicated also.
Chemical Characterization of n-Conotoxins—Table I gives 
the amino acid compositions of the three major toxins as 
measured after 24-h hydrolysis of unmodified peptides, and
1 . 6
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Fig. 1. Chrom atographic purification  of conotoxin GUI on 
VYDAC C18 sem ipreparative column. Solvent A, 0.1% trifluo- 
roacetic acid; Solvent B, 0.1% trifluoroacetic acid in 60% (v/v) 
acetonitrile. Peptides were eluted with linear gradients, expressed as 
per cent Solvent B achieved at times given in parentheses (min); 
0(0)/0(2)/100(52). The arrows indicate peaks corresponding to un- 
derhydroxylated forms of GUI.
T able I
Amino acid analysis of fi-conotoxins 
Results are expressed as mol/mol, normalizing (Lys + Arg + Asx 
+ Glx + Ala) to the nearest integer. Values are uncorrected for 
hydrolysis losses. Figures in parentheses are the numbers of residues 
determined from sequence analysis.
GIIIA GIIIB GIIIC
Lys 4.0 (4) 3.9 (4) 4.9 (5)
Arg 3.0 (3) 4.2 (4) 3.1 (3)
Asx 2.1 (2) 1.9 (2) 2.0 (2)
Thr 0.93 (1) 0.87 (1) 0.93 (1)
Glx 1.8 (2) 0 (0 ) 0 (0 )
Hyp“ 3.1 (3) 3.4 (3) 3.1 (3)
Ala 1.1 (1) 1 . 0  (1) 1 . 0  (1)
V4 Cys6 5.5 (6) 5.1 (6) 4.7 (6)
Met 0 (0 ) 0.86 (1) 0 (0 )
Leu 0 (0 ) 0 (0 ) 1 . 0  (1)
“ Hydroxyproline values are subject to ±10% error. 
6 Measured as cystine, from unmodified peptides.
as deduced from sequence studies. As we had previously 
described for conotoxin GIIIA, all of the peptides contain 3 
mol/mol of trans-4-hydroxyproline (14).
The results of the sequencer analyses are shown on Table 
II, which gives the yields of the amino acids obtained during 
sequencer runs on reduced and carboxymethylated toxins. 
Stepwise repetitive yields were 89-90%. About half of the 
losses were due to tailover, which has been a persistent 
problem with these peptides. It is improved somewhat, but 
not eliminated, by using a double cleavage at hydroxyproline 
residues.
We used a novel procedure for reduction and carboxymeth- 
ylation, based on that of Riiegg and Rudinger (20) which uses 
tributylphosphine. The aim was to avoid purifying small 
amounts of alkylated peptide from large excesses of the usual 
reactants. These peptides are so hydrophilic that their car- 
boxymethyl derivatives elute among the reagent peaks on 
reversed-phase HPLC (data not shown). Although the reac­
tion proceeded smoothly for vasopressin, we found that a side 
reaction can occur with the excess tributylphosphine. It ap­
pears that on addition of iodoacetate a quaternary phosphin- 
ium compound is produced, which can alkylate methionine 
and carboxymethylcysteine, giving derivatives whose phen- 
ylthiohydantoins migrate close to that of Ala. We presume 
that these represent transfer of a butyl group to form sul- 
phonium compounds. The amount formed was variable: about 
50% of Met-18 in GIIIB was modified, while the Cys(Cm) was 
unaffected; in the run shown for GIIIC, the Cys(Cm) was 
modified about 20%.
With GIIIA we experienced very heavy losses of the car- 
boxy-terminal Ala. Its presence was inferred from amino acid 
analysis (Table I), but at step 22 a net increase of only 9 pmol 
above background was obtained. No other amino acid in­
creased, and the rise was statistically significant (previous 9 
steps gave 32 ±  2.5 pmol of Ala; step 22 gave 41). With GIIIB 
an improved yield of Ala-22 was obtained by decreasing the 
chlorobutane wash in the previous three steps, albeit at the 
expense of a lower extraction efficiency for all PTH deriva­
tives in those steps.
For GIIIC the side reaction on Cys(Cm) (see above) pre­
cluded identification, and a separate analysis was made. Ap­
proximately 3 nmol of toxin was performic acid-oxidized, 
acetylated, and trypsin-digested. The results of a sequencer 
analysis are given in Table III. The main cleavage by trypsin 
was between Arg-14 and Cys-15, as evidenced by the prepon­
derance of amino acids corresponding to the sequence 15-22. 
Minor cleavages were also apparent between Lys-8 and Lys- 
9, and between Arg-1 and Asp-2, but these did not interfere 
with identification of the major peptide.
Manual sequencing of conotoxin GIIIA was also carried 
out. Clostripain digestion of reduced and carboxamidometh- 
ylated GIIIA gave a much more complex pattern of splits than 
had been expected. Cleavage after Arg-13 and Arg-19 was 
complete, as far as we could judge: not all peaks were analyzed, 
since our main object was to identify the carboxyl-terminal 
fragment. However, “ragged” cleavage occurred also at Lys-8 
and Lys-9, and possibly at Lys-11, giving several peptide 
fragments of similar compositions. Fragments for which good 
compositional and/or sequence data were obtained are indi­
cated in Fig. 2.
Because the a-conotoxins all have amidated carboxy ter­
mini, we examined the status of this group in the /i-conotox- 
ins. The terminal tripeptide fragment of GIIIA was isolated 
from the clostripain digest of carboxamidomethylated toxin 
and had the composition (Cys2.2, Alai.o) after acid hydrolysis. 













Sequencer analyses of n-conotoxins 
Yields are expressed in pmol, uncorrected for extraction losses. * indicates differences from GIIIA.
GIIIB





















1 Arg 6440 0 6440 Arg 4440 0 4440 Arg 2565 0 2565
2 Asp 7040 1 2 0 6920 Asp 6910 40 6870 Asp 2920 150 2770
3 Cys 5820 760 5060 Cys 6170 480 5690 Cys 1800 380 1420
4 Cys 6040 760 5280 Cys 5640 480 5160 Cys 1780 380 1400
5 Thr 2060 0 2060 Thr 6790 130 6660 Thr 2625 2 0 2605
6 Hyp 4180 65 4120 Hyp 4880 230 4650 Hyp 2035 250 1785
7 Hyp 4180 65 4120 Hyp 4820 230 4590 Hyp 1965 250 1715
8 Lys 2030 2 0 0 1830 *Arg 1910 2 0 0 1710 Lys 1105 145 960
9 Lys 2570 2 0 0 2370 Lys 3110 340 2770 Lys 1720 (705)“ 1015
1 0 Cys 2960 310 2650 Cys 3210 610 2600 Cys 1400 610 790
1 1 Lys 2 2 0 0 2 0 0 2 0 0 0 Lys 4570 340 4230 Lys 1495 150 1345
1 2 Asp 2540 140 2400 Asp 2790 290 2500 Asp 1075 240 835
13 Arg 1645 130 1515 Arg 1940 330 1610 Arg 855 265 590
14 Gin 1870 165 1705 *Arg 2760 (1265)“ 1495 *Arg 1840 (750)“ 1090
15 Cys 2215 375 1840 Cys 2325 635 1690 Cys 965 635 330
16 Lys 1240 170 1070 Lys 2305 490 1815 Lys 735 380 355
17 Hyp 1420 160 1260 Hyp 1680 340 1340 Hyp 750 270 480
18 Gin 1430 2 0 0 1230 •Met 780 80 7006 *Leu 625 125 500
19 Arg 920 130 790 *Lys 735 245 490" *Lys 735 365 370
2 0 Cys 1240 340 900 Cys 620 2 0 0 420c
2 1 Cys 1460 (680)” 780 Cys 840 510 330c
2 2 (Ala) 41 32 9 Ala 90 32 58c
Repetitive Yield1' 90% Repetitive Yield 90% Repetitive Yield 89%
(R1-R19; D2-D12; (R1-R14; D2-D12; (R1-R13; D2-D12;
C3-C15; Hyp-6 - C3-C14; Hyp-6 - C3-C15; Hyp-6 -Hyp-
Hyp-17) Hyp-17) 17)
“ Parentheses indicate that background includes a large contribution from tailover of preceding residue. 
6  Additional peak was present due to alkylation via tributylphosphine (see text).
'  All yields and background peaks dropped about 50%, due to shorter extraction times. 
d Repetitive yields are conservative, based on net pmol.
Table III
Carboxyl region of GIIIC
Yield Background Net pmol
1 Cys“ 335 0 335
2 Lys6 1770 310 1460
3 Hyp 1400 2 0 0 1 2 0 0
4 Leu 1015 2 0 995
5 Lys6 1030 55 975
6 Cys“ 162 81 81
7 Cys” 197 81 116
8 Ala 61 1 0 51
“Analyzed as PTH-cysteic acid, which extracts poorly from the 
sequencer cup.
6 Analyzed as t-N-acetyl-PTH-lysine, which elutes just after PTH- 
Ala on HPLC.
indicating a blocked a-carboxyl. After removal of the two 
residues of carboxamidomethylcysteine by Edman degrada­
tion, the remaining material was dansylated but not hydro­
lyzed. Electrophoresis at pH 4.4 (35) showed no dns-Ala, but 
there was fluorescent material running with the same mobility 
as that of authentic dns-Ala-NH2. This material was eluted, 
hydrolyzed (6 N HC1, 20 h, 105 °C), and rerun at pH 4.4. dns- 
Ala was obtained, confirming the presence of amidated Ala at 
the carboxyl terminus.
Minor Toxin Species: Underhydroxylation—Amino acid 
analysis of the minor active fractions (indicated by arrows in 
Fig. 1) suggested that they might contain peptides related to 
GIIIA and GIIIB, but with 2 Hyp and 1 Pro. They were 
repurified by HPLC to remove possible contamination by 
GIIIB and GIIIC, respectively. Several components were iso­
lated that had approximately the same biological activity on
a molar basis, as judged by peak area from HPLC.
Insufficient material was available for accurate estimation 
of Hyp and Pro by amino acid analysis, but three minor 
variants (approximately 3-4 nmol each) were performic acid- 
oxidized and analyzed in the sequencer.
The earlier peak, after repurification, was found to be a 
mixture of [Pro7]conotoxin GIIIA (approximately 80%) and 
[Pro6]conotoxin GIIIA (approximately 20%). There was no 
detectable contamination by any form of GIIIB or GIIIC, as 
shown by lack of Met and Leu at step 18 of the sequencer 
run: detection limit was 2%.
The later peak contained predominantly GIIIB underhy- 
droxylated at positions 6 and 7. The isomers [Pro6]conotoxin 
GIIIB and [Pro7] conotoxin GIIIB were present in two over­
lapping peaks from rechromatography. Though they were not 
fully resolved, the equal potency of fractions containing dif­
ferent ratios of the two (3:1 and 1:1) suggests strongly that 
both isomers are active. Minor amounts (~6%) of some form 
of GIIIC were present, but no specific structure can be as­
signed.
In these fractions there was no more than 2% of isomers 
that lacked the hydroxyl on Hyp17. We cannot exclude these 
as being present elsewhere in the chromatogram.
Physiological Studies Using Purified fi-Conotoxin GIIIA— 
Application of fiM concentrations of /x-conotoxin GIIIA par­
alyzed an isolated skeletal muscle preparation from frog (cu­
taneous pectoralis) within a few minutes. Intracellular record­
ings from muscle fibers show that the toxin causes paralysis 
by blocking action potentials in the muscle. After exposure to 
3 /iM toxin for 8 min, muscle action potentials were not elicited 





























1 5  10 15 20
Arg-Asp-Cys-Cys-Thr-Hyp-Hyp-Lys-Lys-Cys-Lys-Asp-Arg-Gln-Cys-Lys-Hyp-Gln-Arg-Cys-Cys-Ala-N^
 ^ 7 7 7 7 7 7 ) I 7 7 7 ! 7 > t  t  )----I I I
Conus Peptides That Block Muscle Sodium Channels
Cl 18 . . Cl 9 j .  Cl 11 | |  Cl 6  - 
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Fig. 2. P rim ary  s truc tu res of p-conotoxins, deduced from  sequence analysis and compositions of 
whole toxins and fragm ents. Whole toxins, reduced and carboxymethylated, were analyzed in the sequencer 
(see text and Table II). Clostripain fragments of GUI were separated by reversed-phase HPLC, and analyzed 
manually and/or in the sequencer. The selective trypsin fragment of GIIIC was produced by performic acid 
oxidation, acetylation, and trypsin digestion (see text and Table III). Amino acids positioned by phenylisothio- 
cyanate degradation are indicated by barbs ( ^ )  on the appropriate lines; those whose presence, but not order, is 
suggested by amino acid analysis are indicated by dotted lines. Presence of the carboxy-terminal amide is positively 
established only for GIIIA.
the effect of ^ -conotoxin on the veratridine-induced depolar­
ization of muscle fibers was examined. Veratridine depolarizes 
by opening sodium action potential channels, and tetrodo- 
toxin, the classical sodium channel inhibitor, can block this 
effect of veratridine. Like tetrodotoxin, ^-conotoxin repolar- 
izes veratridine-treated muscle fibers. These results indicate 
that the /i-conotoxin acts by blocking the muscle sodium 
channel. Unlike tetrodotoxin, however, ^-conotoxin does not 
act on sodium channels of nerves at concentrations of at least 
50 ^M. The toxin has also been tested on mouse phrenic nerve 
diaphragm preparations with results similar to those de­
scribed above for frog muscles.
Studies on Single Sodium Channels in Planar Lipid Bilay­
ers—In order to further explore the biochemical basis of pi- 
conotoxin action, planar bilayer methods were used to study 
this toxin’s effect on single sodium channel currents from rat 
muscle (28) or rat brain synaptosomes (29, 33) measured at 
constant voltage. In these experiments, sodium channels from 
native membrane vesicles are incorporated into planar phos­
pholipid bilayers in the presence of batrachotoxin, an agent 
belonging to the class of lipophilic activators along with 
veratridine (4). Batrachotoxin has been previously shown to 
specifically eliminate the voltage-dependent inactivation 
process of the sodium channel and also shift the voltage 
dependence of activation by about 50 mV more negative than 
normal channels (28, 33, 36, 37). In the voltage range of —50 
to +50 mV, the batrachotoxin-activated channel from muscle 
is open 95% of the time, with the remaining 5% composed of 
short-lived closing events on the order of 100 ms in duration 
(28). This behavior is illustrated in Fig. 4A, which shows a 
typical current record -at +50 mV from a bilayer containing 
two muscle Na+ channels in the presence of 0.2 /iM batrach­
otoxin and 0.2 M NaCl on both sides of the bilayer. In this 
control record, when the voltage is changed from 0 to +50
Fig. 3. The in tracellu la r responses of a muscle fiber w ere 
m onitored while the fiber w as stim ulated directly  (left) or 
indirectly  via its m otor nerve (r igh t). Arrows point to stimulus 
artifacts. Top trace, control action potentials obtained by direct and 
indirect stimulation in absence of toxin. Bottom trace, response after 
8  min in /j-conotoxin GIIIA (3 /:M). In the bottom trace, action 
potentials in response to both direct and indirect stimulation are 
essentially completely blocked, whereas the end plate potential in 
response to indirect stimulation persists. Control responses were 
obtained after toxin was washed out, showing reversibility of toxin 
effects. To prevent muscle movement during stimulation, excitation 
contraction coupling was blocked by treatment with formamide (27).
did not block synaptic transmission, and end plate potentials 
could still be evoked by stimulating the motor nerve (Fig. 3). 
since action potentials in the nerve terminal are normally 
essential for neuromuscular transmission in frog (32), this 
observation indicates that action potentials in nerve are not 
blocked by the toxin under these conditions, although action 
potentials in muscle are. Similar results were obtained with 
50 juM toxin, with exposures of up to 15 min, showing that 
the action is highly selective for muscle.
One way in which the /j-conotoxin could affect muscle 
action potentials is by blocking sodium channels that are 
























A. muscle, +50m V
B. muscle, +50mV
O.SpM Mconotoxln
C. muscle, — BOmV
O.BpM iiconotoxln
L .. ...... .. .III ............................. ..
.it •' >•. i -1 ! r • i . y  ii. i ii k . i ylt , *•
1 |_______ .
30 sec
D. brain, -BOmV ^
1.0 mm pconotoxln > ■- » . • » .1 » • • M T r •, " . j ' . ' ' '
I IM—»!*« ■ i i IlK ll in^ ll d <1 > .nw.mu
E. brain,+50mV 
50 nM tetrodotoxin
■V'./ i . i . l i t* .
i>4i|»ii|iiiinr miinp»>
■ J U -  '’‘I'' ' -
6 sec
Fig. 4. M-Conotoxin block specific for muscle Na+ channels observed a t the single channel level.
Batrachotoxin-activated Na+ channels were incorporated into planar lipid bilayers from plasma membrane 
preparations of adult rat skeletal muscle or brain as described previously (28, 29). Lipid bilayers were cast from a 
solution of 20 mg/ml of phosphatidylethanolamine and 5 mg/ml of phosphatidylcholine in decane. The bath on 
both sides of the bilayer contained 10 mM MOPS-NaOH, pH 7.4, 0.2 M NaCl, 0.1 mM EDTA, 0.2 ^M batrachotoxin 
at 22 °C. The indicated concentration of ^-conotoxin GIIIA and 0.2 mg/ml of bovine serum albumin was present 
on the side corresponding to the extracellular face of the channel. The sign of the voltage is referred to using the 
physiological intracellular convention. The horizontal arrow at the left of each trace corresponds to the zero current 
level. In A, B, and E, opening is in the upward direction at positive voltage; in C and D, opening is in the downward 
direction at negative voltage. In B, C, and D, the vertical arrow marks when the holding voltage was changed from 
0 mV to the indicated value as noted by the capacitative transient. In B and E, representative segments of long 
records are shown. A, example of a bilayer containing two muscle Na+ channels at +50 mV; virtually identical 
behavior is observed at —50 mV as previously described (28). B, a different bilayer than A containing one muscle 
Na+ channel at +50 mV in the presence of 0.5 nM GIIIA. Silent periods of no channel activity correspond to 
blocked states. C, the same bilayer as in B at -50  mV. D, a bilayer containing one brain Na+ channel at -50 mV 
in the presence of 1 fiM GIIIA on the extracellular side of the channel. E, a record from the same bilayer as in D 
after addition of 50 nM tetrodotoxin to the same side as that containing GIIIA. The time scale here is five times 
faster than for traces A-D.
mV, the current is observed to relax to a steady level of 2 pA 
after the capacitative transient. Occasional brief closing 
events of 1-pA amplitude (20 pS conductance) are observed, 
which correspond to the closing of either of the two channels 
in the bilayer by an inherent gating process. The control 
behavior at —50 mV is essentially identical to that at +50 mV 
(28).
In the presence of ^-conotoxin GHIa, a new phenomenon 
is observed as shown in Fig. 4B. GIIIA induces the appearance 
of long-lived discrete blocked states in the current records. 
This behavior is similar to that of channels blocked by tetro­
dotoxin and a series of natural saxitoxin derivatives that have 
been documented for the rat brain (33, 38) and rat muscle 
(28, 34) Na+ channel in bilayers. Two additional characteris­
tics of tetrodotoxin and saxitoxin action are also exhibited by 
GIIIA: block is only observed when toxin is present on the 
extracellular side of the channel (not shown),3 and the block­
ing activity is voltage-dependent, increasing with hyperpolar­
ization. The latter effect is shown qualitatively by the typical 
record of Fig. 4C, where the channel is blocked for longer 
periods at —50 than +50 mV (Fig. 4B). Aside from these 
similarities, the duration of the blocked periods induced by 
GIIIA is longer than that of any saxitoxin derivative tested
3 The orientation of the channel in the bilayer can be independently 
verified by examining its behavior at —100 mV, i.e. hyperpolarizing 
voltage closes the channel (28, 33, 38).
to date. For example, the average duration of blocking events 
at —25 mV is 250 s for GIIIA, while that of the most potent 
saxitoxin derivative (neosaxitoxin) is 120 s at this voltage 
(34).
In contrast to the immediate and routinely observed effect 
of GIIIA on muscle sodium channels, no effect was observed 
when sodium channels from rat brain synaptosomes were 
studied. An example of this result is shown in Fig. AD, where 
a brain channel in the presence of 1 nM GIIIA is shown at 
—50 mV. Under these conditions, the rat muscle channel was 
blocked greater than 90% of the time. To verify that the 
channel in Fig. 4D is indeed a Na+ channel, 50 nM tetrodo­
toxin was added to the same side of the bilayer as the 1 fiM 
GIIIA. In Fig. 4E, a segment of a record at +50 mV shows 
that this /i-conotoxin-insensitive rat brain Na+ channel is 
blocked by tetrodotoxin, as previously documented (33, 39).
In order to quantitate the effect of GIIIA on the muscle 
channel, the stochastic blocking kinetics of single channels 
were analyzed as previously described for tetrodotoxin (28). 
As predicted by a single-site, reversible binding equilibrium, 
the probability distributions of the blocked and unblocked 
dwell time events conform to exponential distribution as 
shown in Fig. 5A for data taken at +25 mV. Also, as shown 
in Fig. 5B, the reciprocal of the mean unblocked time is 
directly proportional to GIIIA concentration, while the mean 























Fig. 5. K inetics of GIIIA blocking of single batrachotoxin-activated  Na+ channels from  ra t muscle 
in  p lan ar bilayers. A, cumulative probability distribution histogram compiled from 78 blocked (•)  and unblocked 
(O) events measured at +25 mV and 0.25 hM GIIIA. The ordinate corresponds to the probability that an event is 
greater than a given time on the abscissa axis. The data were fitted to exponential distributions with time constants 
as indicated. B, dependence of the reciprocal mean blocked time, ft-1, (•) or reciprocal mean unblocked time, t „ _ 1 , 
(O) on GIIIA concentration. Mean values at different concentrations were measured from populations of 70-100 
events. The horizontal line corresponds to the mean dissociation rate constant, 0.016 s-1, of the three values of 
t j " 1. The slope of the linear fit of r „ _1 versus [GIIIA] corresponds to a bimolecular association rate constant of 4.8 
x  104 s- 1  M-1. C, voltage dependence of association (O) and dissociation ( • )  rate constants measured from mean 
dwell times in the presence of 0.5 txM GIIIA. The equilibrium dissociation constant, KD (A) was calculated as the 
ratio, kotf/kon. Fits to exponential functions of voltage are given in the text.
results of Fig. 5, A and B, identify the blocked periods as the 
dwell times of individual GIIIA molecules bound to the chan­
nel and the unblocked periods as the individual waiting times 
for a GIIIA molecule to bind (39). For such a simple exponen­
tial binding process, the reciprocals of mean blocked and 
unblocked times at any voltage give the rate constants for 
dissociation and association, respectively. The bimolecular 
association rate constant can be obtained from the slope of 
the pseudo-first order rate constant versus concentration (Fig. 
5B). In Fig. 5C, the derived dissociation and association rate 
constants for experiments at 0.5 nM GIIIA are plotted versus 
applied voltage. The dissociation rate constant was found to 
vary exponentially with voltage as previously documented for 
tetrodotoxin and saxitoxin (28, 33, 34). However, the associ­
ation rate constant of GIIIA exhibits little or no dependence 
on voltage. The ratio of the two rate constants, or the equilib­
rium Kd, is also plotted in Fig. 5C. The data in Fig. 5C were 
fitted to exponential functions of voltage to obtain the follow­
ing relationships, where the voltage, V, is in mV.
kodV)  =  7 x  10_3exp(0.026 V) s ' 1 
k0n(V) =  6 x  104exp(—0.003 V) s"’ 
Kd( V) =  1.1 x  1 0 '7exp(0.029 V) m
M
GIIIA exhibits an e-fold increase in KD/ 34 mV of depolariza­
tion, a voltage dependence similar to that previously reported 
for tetrodotoxin blocking of rat muscle or rat brain channels 
in planar bilayers (28, 33, 34, 38).
DISCUSSION
The family of n -conotoxins described above is one of several 
functionally distinct classes of peptide toxins isolated from 
the venom of the marine snail C. geographus. Other peptide 
toxins in the venom include the aj-conotoxins, which inhibit 
Ca2+ channels at the presynaptic terminus, and the a-cono- 
toxins, which block acetylcholine receptors at the postsynap- 
tic terminus. We have directly demonstrated in this report
that one /i-conotoxin, /i-conotoxin GIIIA, blocks muscle Na+ 
channels. Given the tight homology of these peptides, it seems 
likely that the muscle Na+channel is the primary physiological 
target of all /i-conotoxins. Thus the venom of C. geographus 
has 3 toxin families, the a-, o>-, and /^-conotoxins, which block 
successive steps in neuromuscular signal transmission.
Chemically, we have isolated and characterized seven active 
peptides of this series. All ^-conotoxins isolated to date are 
highly basic, 22-amino acid peptides rich in Cys residues 
(Table II). Purification to homogeneity has allowed us to 
demonstrate that one member of this particular group is 
highly selective in blocking the voltage-activated sodium 
channels of muscle membrane, while having no effect on those 
of nerve membranes.
Three of the ji-conotoxins, GIIIA, GIIIB, and GIIIC, are 
different in primary structure and presumably coded by dif­
ferent genes. The first of these most closely corresponds to 
toxin III described by Spence et al. (13), and geographutoxin
I of Nakamura et al. (15); GIIB corresponds to geographutoxin
II of these authors (15). Previously, we showed that GIIIA 
contained hydroxyproline (14), and Sato et al. (16) reported 
the amino acid sequences of GIIIA and GIIIB. In all three 
primary forms of the toxins, there are 3 residues of hydroxy­
proline, which is present in sequences different from those 
found in collagen. Presumably the hydroxylation enzymes are 
quite distinct.
The role of hydroxyproline in the toxins is unclear. Four 
underhydroxylated variants were isolated in low yield, and we 
suspect that other minor forms are also present. Although 
quantities were very limited, it was clear that the underhy­
droxylated forms of GIIIA and GIIIB are biologically active, 
as detected both by injection in vivo and by electrophysiolog- 
ical studies on nerve-muscle preparations. We obtained 6-Pro 
and 7-Pro variants of these peptides but did not detect any 
17-Pro. This might reflect a somewhat less efficient activity 
































could also be explained by failure to separate the 17-Pro 
variants from the major forms. Hydroxylation is thus very 
efficient at all three positions in the /i-conotoxins. Conus 
venom prolyl hydroxylase does show specificity, however, 
since the a-conotoxins in the same venom contain exclusively 
the unmodified Pro, while the aj-conotoxins have hydroxypro- 
line (31). Chemical synthesis of proline-containing variants 
may be simpler than that of the fully hydroxylated forms and 
should allow a much more thorough study of the role of 
hydroxylation in biological function.
The major significance of the ji-conotoxins resides in their 
unique physiological activity. Both electrophysiological ex­
periments and studies using single channels in lipid bilayers 
indicate that /i-conotoxin GIIIA blocks muscle Na+ channels 
but has little or no activity on those from nerve and brain. 
Even at concentrations >15-fold higher than those which 
completely abolish muscle action potentials, the toxin did not 
affect propagation of nerve action potentials. These results 
with the purified ji-conotoxin GIIIA are sufficient to account 
for the selective effects of the crude venom on muscle action 
potential.
The tentative conclusion drawn from early studies using 
crude venom was that the Na+ channel was unlikely to be the 
toxin target (12). Spence et al. (13) were the first to suggest 
that the toxin might “block the inward movement of Na ions 
during activity,” although the hypothesis was not further 
explored. Their toxin preparation caused an inactivation of 
nerve action potentials as well. In order to explain the dis­
crepancy with Endean’s results with crude venom (12), it was 
suggested that the failure of crude venom to inactivate nerve 
action potentials was “most likely to be the result of poor 
penetration of the active peptide into the nerve bundle com­
bined with inadequate dosing” (13). This implied that their 
toxin might not really discriminate between nerve and muscle 
Na+ channels.
The results presented above strongly indicate that /i-cono- 
toxin GIIIA can intrinsically distinguish between nerve and 
muscle Na+ channels. Arguments that the discrimination 
observed may be due to selective access can be discounted for 
two reasons: first, the discrimination is found even in recon­
stituted lipid bilayers, where access should be unrestricted; 
and second, the much larger scorpion toxins interact with 
both nerve and muscle sodium channels (4), implying that 
access is not a critical problem even in intact nerve and 
muscle. We are unable to explain the results of Spence et al. 
(13) on nerve action potentials; in some of the studies above, 
higher toxin concentrations were used than in their work. 
One note of caution: all our results on discrimination to date 
have been obtained with the major variant, GIIIA. Although 
it seems likely that all /i-conotoxins inhibit muscle Na+ chan­
nels, it remains to be established whether other variants and 
underhydroxylated forms discriminate as effectively against 
neuronal channels.
In addition to confirming the selective action of GIIIA on 
muscle Na+ channels, the planar bilayer method was used to 
analyze the kinetics of /i-conotoxin block of single batracho­
toxin-activated channels. The results of this study reveal 
essential similarities between the effect of GIIIA and that of 
tetrodotoxin or saxitoxin studied by the same method: an 
effect is only observed on the extracellular side of the channel, 
discrete blocked states of zero conductance are induced, the 
kinetics follow a reversible equilibrium of binding to a single 
site, and binding increases with hyperpolarizing voltage. On 
the other hand, certain aspects of GIIIA action contrast with 
that of tetrodotoxin and saxitoxin: both the association and 
dissociation rate constants of GIIIA are slower than that of
any saxitoxin derivatives examined to date (34), and most of 
the voltage dependence of GIIIA binding resides in the dis­
sociation step (e-fold/40 mV), while both the association and 
dissociation reactions of saxitoxin derivatives have similar 
voltage dependence (e-fold/80 mV) (34). The similarities of 
GIIIA action on muscle channels, compared to the guanidin- 
ium toxins, leads us to suspect that GIIIA may share part of 
the tetrodotoxin/saxitoxin receptor site. To address this ques­
tion, binding competition between the /^-conotoxins and sax­
itoxin will be the subject of future investigations using radio­
labeled toxins. Also, once the M-conotoxins are available in 
radioactive form, it may be possible to directly quantitate the 
proportion of binding sites homologous to skeletal muscle Na+ 
channels in various tissues. While the present bilayer results 
demonstrate that GIIIA-insensitive Na+ channels exist in 
brain synaptosomes, this method is inappropriate for measur­
ing the proportion of such channels.
The strong specificity of /x-conotoxin for muscle versus 
nerve is surprising, given the functional and electrophysiolog­
ical similarities of nerve and muscle sodium channel currents 
(40). A comparison of published data on selectivity, conduct­
ance, gating, and pharmacology for the batrachotoxin-acti­
vated channel from muscle (28, 34) and brain (33, 38) in 
planar bilayers reveals few differences between the single 
channels from these tissues as dramatic as the GIIIA results. 
However, it was previously suspected that the two channels 
might not be identical, since the brain channel has a distinctly 
larger conductance, about 20% greater than that of the muscle 
channel (28).
We can only estimate a lower limit for the selectivity of 
GIIIA for muscle versus nerve, since no effect was observed 
at 1 fxM in the bilayer system and at 50 /uM for intact nerve 
experiments. Assuming that the KD of GIIIA for nerve is 
greater than 100 /uM at 0 mV, the minimum value of the KD 
ratio for nerve/muscle is 103, using the muscle KD of 0.1 /iM 
at 0 mV, measured here. To temper our emphasis of the 
difference between the nerve and muscle channels, it should 
be pointed out that such differences in the free energy of 
binding can be achieved by a minor structural modification 
in the toxin receptor site, perhaps an alteration of only one 
amino acid. Although the nerve/muscle discrimination of n- 
conotoxin is novel, it has been previously proposed that tissue- 
specific variants of Na+ channels may exist as demonstrated 
by differences in sensitivity or binding of saxitoxin, tetrodo­
toxin, their derivatives, and other Na+ channel toxins (41­
45). The availability of /x-conotoxin provides an additional, 
highly tissue-specific probe of Na+ channel structure.
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